…ilisin/kexin type 9 inhibitors (PCSK9i), such as alirocumab and evolocumab, effectively manage cLDL levels. However, the relative efficacy…
ezetimibe
This drug is selected. Its supporting articles are shown below.
Articles mentioning ezetimibe
30 articles · page 1 of 3….31 discounted QALYs at a lifetime cost of 166,513 units, while bempedoic acid yielded 11.01 discounted QALYs at 389,310 units. Compared with …
…isease, and three with familial hypercholesterolaemia. Prior to inclisiran, 11 patients (28.9%) had been treated with evolocumab and 2 pat…
…arget (111) Off target (197) Both groups (308) Statin% 95 85 89 Atorvastatin Total Number% 62 61 62 Mean Dose (mg) 57.71 (SD 25.03) 58.33 (S…
… bempedoic acid, and 2% received a combination of Ezetimibe and bempedoic acid. No patients were initiated on PCSK9 inhibitors.Abstract 7-007 …
… included (40% women; 60±7 years), all in secondary prevention. Inclisiran was indicated for failure to reach LDL-C targets despite optima…
…randomised 1:1 to receive either moderate-intensity statin with ezetimibe (rosuvastatin 5 mg with ezetimibe 10 mg) or high-intensity stat…
…80 mg or equivalent on admission 88.15%(n=67)93.8% (n=61)p=0.22 Ezetimibe 10 mg on admission 65.7%(n=50)73.8% (n=48)p=0.56 PCSK9 inhibito…
…ients reporting mild local injection site irritation.Conclusion Inclisiran significantly reduces LDL cholesterol levels, with the greatest…
…ts, only 3 (8.3%) had therapy intensified limited to the use of ezetimibe, highlighting a critical gap in care.Abstract 7-010 Table 1 Var…
…HMG CoA) reductase inhibitors (statins), alone or combined with ezetimibe, are the most extensively studied treatment in reducing cholest…
…. cData missing for 14 patients.BA, bempedoic acid; BA+EZE-FDC. Bempedoic acid/ezetimibe fixed-dose combination; HeFH, heterozygous familial h…